Search Results
Results found for "Kari Johnson"
Posts (10)
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Elizabeth Johnstone were awarded one of the 2022 Diabetes Research Grants at the World Diabetes Day Breakfast "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline
Other Pages (5)
- Ep 22 with Dr. Kari Johnson
Kari Johnson About this episode Dr. Kari Johnson is currently an assistant professor at the Uniformed Services University of the Health Sciences Kari completed her Ph.D. in Pharmacology at Vanderbilt University before continuing her training as a Join me and learn more about how Kari studies GPCRs in basal ganglia circuits following chronic alcohol Kari Johnson on the web LinkedIn Google Scholar Research Gate USU Twitter Dr.
- Celtarys Research | Dr. GPCR Ecosystem
over 20 years of experience in the medtech and diagnostics industries, having held senior roles at Johnson & Johnson and Danaher across the EMEA region in sales, marketing, and general management. Maria Majellaro earned her degree in Pharmaceutical Chemistry and Technology from the University of Bari
- Ep 105 with Annabelle Milner
She began her Ph.D. at Imperial College London with Prof Aylin Hanyaloglu, Prof Gary Frost, and Dr.
